$LTBR
LIGHTBRIDGE Corp Stock $ltbr

$ltbr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000147793223003303 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.600M	$1.866M
YoY Change	11.14%	-2.49%
% of Gross Profit
Research & Development	$366.9K	$448.0K
YoY Change	121.7%	70.47%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.964M	$2.314M
YoY Change	22.34%	6.32%
Operating Profit	-$1.964M	-$2.283M
YoY Change	29.05%	11.2%
Interest Expense	$290.0K	$256.4K
YoY Change	1424.71%	7203.99%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.672M	-$2.027M
YoY Change	11.29%	-1.12%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.672M	-$2.027M
YoY Change	11.29%	-1.12%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.14	-$0.17
Diluted Earnings Per Share	-$0.14	-$0.17
COMMON SHARES
Basic Shares Outstanding	12.13M shares	12.13M shares
Diluted Shares Outstanding		11.67M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.20M	$28.05M
YoY Change	-3.64%	-0.62%
Cash & Equivalents	$28.20M	$28.05M
Short-Term Investments
Other Short-Term Assets	$355.6K	$393.4K
YoY Change	-13.12%	-29.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$28.56M	$28.44M
YoY Change	-3.77%	-1.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$489.8K	$345.0K
YoY Change
Total Long-Term Assets	$598.0K	$453.2K
YoY Change	454.92%	346.18%
TOTAL ASSETS
Total Short-Term Assets	$28.56M	$28.44M
Total Long-Term Assets	$598.0K	$453.2K
Total Assets	$29.16M	$28.90M
YoY Change	-2.11%	0.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$92.72K	$176.0K
YoY Change	-7.28%	75.98%
Accrued Expenses	$500.0K	$400.0K
YoY Change	25.0%	300.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$592.7K	$576.0K
YoY Change	22.8%	27.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$592.7K	$576.0K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$592.7K	$576.0K
YoY Change	22.8%	27.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$148.2M	-$146.5M
YoY Change	5.44%
Common Stock	$12.49K	$12.13K
YoY Change	13.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.56M	$28.32M
YoY Change
Total Liabilities & Shareholders Equity	$29.16M	$28.90M
YoY Change	-2.11%	0.04%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.672M	-$2.027M
YoY Change	11.29%	-1.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.431M	-$1.580M
YoY Change	26.09%	-18.3%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.583M	$731.1K
YoY Change	-27.44%	-86.49%
NET CHANGE
Cash From Operating Activities	-1.431M	-$1.580M
Cash From Investing Activities	0.000	$0.00
Cash From Financing Activities	1.583M	$731.1K
Net Change In Cash	152.7K	-$848.7K
YoY Change	-85.33%	-124.39%
FREE CASH FLOW
Cash From Operating Activities	-$1.431M	-$1.580M
Capital Expenditures	$0.00
Free Cash Flow	-$1.431M
YoY Change	26.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1865929	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	448044	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	393437	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	28444740	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1913564	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	262823	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2176387	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	345000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	108225	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001084554
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	ltbr	Operating Leases Rents Expense Net OperatingLeasesRentsExpenseNet	24000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34487
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	LIGHTBRIDGE CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1975651
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	11710 Plaza America Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2000
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Reston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20190
CY2023Q1	dei	City Area Code CityAreaCode	571
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	730-1200
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	LTBR
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	us-gaap	Assets Assets	28897965	usd
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12129688	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28051303	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11900217	shares
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2313973	usd
CY2023Q1	ltbr	Contributed Services Research And Development ContributedServicesResearchAndDevelopment	31028	usd
CY2022Q1	ltbr	Contributed Services Research And Development ContributedServicesResearchAndDevelopment	123353	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	31028	usd
CY2022Q1	us-gaap	Other Operating Income OtherOperatingIncome	123353	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2282945	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2053034	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	3505	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2026580	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2026580	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2049529	usd
CY2023Q1	ltbr	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.17
CY2022Q1	ltbr	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.20
CY2023Q1	ltbr	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	11673736	shares
CY2022Q1	ltbr	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	10283280	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2026580	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2049529	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	284360	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	264936	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	278173	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	445325	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	440647	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	296305	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1579746	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1933613	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	731052	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5412863	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	731052	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5412863	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-848694	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3479250	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28899997	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24747613	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28051303	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28226863	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	ltbr	Payment Of Accrued Liabilities With Common Stock PaymentOfAccruedLiabilitiesWithCommonStock	215000	usd
CY2022Q1	ltbr	Payment Of Accrued Liabilities With Common Stock PaymentOfAccruedLiabilitiesWithCommonStock	15000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29118155	usd
CY2023Q1	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	731052	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	215000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	284360	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2026580	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28321987	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	24791127	usd
CY2022Q1	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	5412863	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	264936	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2049529	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	28434397	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Interest Income Securities Us Treasury InterestIncomeSecuritiesUSTreasury	20000000.0	usd
CY2022	us-gaap	Interest Income Securities Us Treasury InterestIncomeSecuritiesUSTreasury	19900000	usd
CY2023Q1	us-gaap	Deposits Deposits	8100000	usd
CY2022Q4	us-gaap	Deposits Deposits	9000000.0	usd
CY2023Q1	ltbr	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-2000000.0	usd
CY2022Q1	ltbr	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-2000000.0	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11673736	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10283280	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2000000.0	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2000000.0	usd
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q1	ltbr	Net Loss Diluted NetLossDiluted	-2000000.0	usd
CY2022Q1	ltbr	Net Loss Diluted NetLossDiluted	-2000000.0	usd
CY2023Q1	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	11673736	shares
CY2022Q1	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	10283280	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2023Q1	ltbr	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	11673736	shares
CY2022Q1	ltbr	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	10283280	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2023Q1	ltbr	Warrants Outstanding WarrantsOutstanding	0	shares
CY2022Q1	ltbr	Warrants Outstanding WarrantsOutstanding	45577	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	525903	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	543297	shares
CY2023Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	416316	shares
CY2022Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	188588	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	942219	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	777462	shares
CY2022Q4	ltbr	Total Common Stock And All Common Stock Equivalents TotalCommonStockAndAllCommonStockEquivalents	12426120	shares
CY2023Q1	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	200000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	200000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	200000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	200000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	200000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	600000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	400000	usd
CY2023Q1	ltbr	Operating Lease Term OperatingLeaseTerm	P12M
CY2023Q1	ltbr	Operating Lease Monthly Payment OperatingLeaseMonthlyPayment	8000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2023Q1	ltbr	Operating Leases Rents Expense Net OperatingLeasesRentsExpenseNet	24000	usd
CY2023Q1	ltbr	Project Task Tatement Postemployment Obligations ProjectTaskTatementPostemploymentObligations	3200000	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12126030	shares
CY2023Q1	ltbr	Outstanding Restricted Stock Awards OutstandingRestrictedStockAwards	416316	shares
CY2023Q1	ltbr	Stock Options Outstanding StockOptionsOutstanding	525903	shares
CY2023Q1	ltbr	Stock Options Vested StockOptionsVested	514513	shares
CY2023Q1	ltbr	Total Common Stock And All Common Stock Equivalents TotalCommonStockAndAllCommonStockEquivalents	12651933	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11900217	shares
CY2022Q4	ltbr	Outstanding Restricted Stock Awards OutstandingRestrictedStockAwards	416316	shares
CY2022Q4	ltbr	Stock Options Outstanding StockOptionsOutstanding	525903	shares
CY2022Q4	ltbr	Stock Options Vested StockOptionsVested	514513	shares
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	0	usd
CY2022Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	0	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	300000	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	300000	usd
CY2023Q1	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	300000	usd
CY2022Q1	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	300000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
ltbr-20230331_def.xml	Edgar Link	unprocessable
ltbr-20230331_cal.xml	Edgar Link	unprocessable
0001477932-23-003303-index-headers.html	Edgar Link	pending
0001477932-23-003303-index.html	Edgar Link	pending
0001477932-23-003303.txt	Edgar Link	pending
0001477932-23-003303-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ltbr-20230331.xsd	Edgar Link	pending
ltbr_10q.htm	Edgar Link	pending
ltbr_ex311.htm	Edgar Link	pending
ltbr_ex312.htm	Edgar Link	pending
ltbr_ex32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
ltbr-20230331_lab.xml	Edgar Link	unprocessable
ltbr-20230331_pre.xml	Edgar Link	unprocessable
ltbr_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LTBR
LIGHTBRIDGE Corp Stock $ltbr

2023 Q2 Form 10-Q Financial Statement

#000147793223003303 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTBR LIGHTBRIDGE Corp Stock $ltbr

2023 Q2 Form 10-Q Financial Statement

#000147793223003303 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTBR
LIGHTBRIDGE Corp Stock $ltbr